Apoptosis induced by (di-isopropyloxyphoryl-Trp)2-Lys-OCH 3 in K562 and HeLa cells

Journal of Biosciences

Volumn 33, Issue 1, 2008, Pages 55-62

  Liu, Feng ^a   Liu, Shi Ying ^a   Xu, Ping ^b   Xie, Zhen Hua ^a   Cai, Guo Ping ^a   Jiang, Yu Yang ^a  

^a TSINGHUA UNIVERSITY   (China)

^b HENAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Apoptosis; Cell cycle; HeLa; K562; N phosphoryl dipeptide methyl ester

Indexed keywords

ANNEXIN; ANTINEOPLASTIC AGENT; LYSINE DERIVATIVE; PHOSPHATIDYLSERINE; TRYPTOPHAN DERIVATIVE;

APOPTOSIS; CANCER; CYTOLOGY; DRUG; ESTER; EXPERIMENTAL STUDY; FLOW CYTOMETRY; LABORATORY METHOD;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL POPULATION; CELL PROLIFERATION; CELL STRAIN K 562; CONTROLLED STUDY; DEVICE; DOSE TIME EFFECT RELATION; DRUG SYNTHESIS; FLUORESCENCE ACTIVATED CELL SORTING; HELA CELL; HUMAN; HUMAN CELL; IC 50; SIGNAL TRANSDUCTION;

ANNEXINS; APOPTOSIS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; G2 PHASE; HELA CELLS; HUMANS; INHIBITORY CONCENTRATION 50; K562 CELLS; MITOSIS; MOLECULAR STRUCTURE; OLIGOPEPTIDES; PHOSPHOPEPTIDES; S PHASE; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS;

EID: 41649109213     PISSN: 02505991     EISSN: 02505991     Source Type: Journal    
DOI: 10.1007/s12038-008-0001-3     Document Type: Article

References (28)

1. Bertenshaw S R, Rogers R S, Stern M K, Norman B H, Moore W M, Jerome G M, Branson L M, McDonald J F, McMahon E G and Palomo M A 1993 Phosphorus- containing inhibitors of endothelin converting enzyme: effects of the electronic nature of phosphorus on inhibitor potency; J. Med. Chem. 36 173-176
2. Cai Y M, Gao X, Huang X T, Wang T J and Zhao Y F 2006 Synthesis, spectral characterization and biological activities of phosphoryl amino acid esters; Chinese J. Org. Chem. 26 1677-1681
3. Cheng C M, Liu X H, Li Y M, Ma Y, Tan B, Wan R and Zhao Y F 2004 N-phosphoryl amino acids and biomolecular origins; Origins Life Evol. Biosphere 34 455-464
4. Hanahan D and Weinberg R A 2000 The hallmarks of cancer; Cell 100 57-70
5. Jacobson M D, Weil M and Raff M C 1997 Programmed cell death in animal development; Cell 88 347-354
6. Ji G J, Xue C B, Zeng J N, Li L P, Chai W G and Zhao Y F 1988 Synthesis of N-(diisoproxy phosphoryl) amino acids and peptide; Synthesis 6 444-448
7. Johnstone R W, Rue. i A A and Lowe S W 2002 Apoptosis: a link between cancer genetics and chemotherapy; Cell 108 153-164
8. Jordan M A, Wendell K, Gardiner S, Derry W B, Copp H and Wilson L 1996 Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death; Cancer Res. 56 816-825
9. Kastan M B, Canman C E and Leonard C J 1995 P53, cell cycle control and apoptosis: implications for cancer; Cancer Metastasis Rev. 14 3-15
10. Kidd V J 1998 Proteolytic activities that mediate apoptosis; Annu. Rev. Physiol. 60 533-573
11. Kornblau S M 1998 The role of apoptosis in the pathogenesis, prognosis, and therapy of hematologic malignancies; Leukemia 12 S41-S46
12. Kortylewicz Z P 1990 Phosphoramidate peptide inhibition of human skin . broblast collagenase; J. Med. Chem. 33 263-273
13. Li P, Nijhawan D, Budihardjo I, Srinivasula S M, Ahmad M, Alnemri E S and Wang X D 1997 Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade; Cell 91 479-489
14. Mosmann T 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytoxicity assays; J. Immunol. Methods 65 55-63
15. Nagata S 1997 Apoptosis by death factor; Cell 88 355-365
16. Nay. eld S G, Karp J E, Ford L G, Dorr F A and Kramer B S 1991 Potential role of tamoxifen in prevention of breast cancer; J. Natl. Cancer Inst. 83 1450-1459
17. Niu Y L, Du W, Jiang Y Y, Cao S L and Zhao Y F 2001 Apoptosis of HCT-15 cell lines induced by a kind of N-phosphoryl branched dipeptide; J. Tsinghua Univ. 7 101-103 (S1)
18. Reeves J P 1979 Accumulation of amino acids by lysosomes incubated with amino acid methyl esters; J. Biol. Chem. 254 8914-8921
19. Sausville E A, Elsayed Y, Monga M and Kim G 2003 Signal transduction-directed cancer treatments; Annu. Rev. Pharmacol. Toxicol. 43 199-231
20. Schulte-Hermann R, Bursch W, Low-Baselli A, Wagner A and Grasl-Kraupp B 1997 Apoptosis in the liver and its role in hepatocarcinogenesis; Cell. Biol. Toxicol. 13 339-348
21. Smets A 1994 Programmed cell death (apoptosis) and response to anti-cancer drugs; Anticancer Drugs 5 3-9
22. Thiele D L 1992 Apoptosis is induced in cells with cytolytic potential by L-leucyl-L-leucine methyl ester; J. Immunol. 148 3950-3957
23. Thiele D L and Lipsky P E 1985 Modulation of human natural killer cell function by L-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononuclear cells; J. Immunol. 134 786-793
24. Thompson C B 1995 Apoptosis in the pathogenesis and treatment of disease; Science 267 1456-1462
25. Van Engeland M, Nieland L J W, Ramaekers F C S, Schutte B and Reutelingsperger C P M 1998 Annexin V-af. nity assay: a review on an apoptosis detection system based on phosphatidylserine exposure; Cytometry 31 1-9
26. Yang J, Jiang Y Y, Liu F and Zhao Y F 2006 Mitochondria-regulated death pathway mediates (DIPP-L-Leu)(2)-LLysOCH( 3)-induced K562 cells apoptosis; Protein Peptide Lett. 13 129-134
27. Zhao Y F, Ju Y, Li Y M, Wang Q, Yin Y W and Tan B 1995 Self-activation of N-phosphoamino acids and N-phosphodipeptide in oligopeptide formation; Int. J. Peptide Protein Res. 45 514-518
28. Zhao Y F, Zhang J C, Cao S X, Xu J, Rong C L and Qu L B 2004 Synthesis of N-(diisopropyloxyphosphoryl) amino acids; Chinese J. Org. Chem. 24 609-615